Difference between revisions of "Thyroid Disease"
(Page created) |
m (→Unacceptable) |
||
| Line 17: | Line 17: | ||
Any thyroid disorder under investigation; | Any thyroid disorder under investigation; | ||
| − | Graves (hyperthyroidism or thyrotoxicosis) | + | Graves disease (hyperthyroidism or thyrotoxicosis) within six months of treatment with radioactive iodine therapy; |
Graves disease (hyperthyroidism or thyrotoxicosis) within 2 years of completing anti-thyroid tablet therapy (e.g. carbimazole); | Graves disease (hyperthyroidism or thyrotoxicosis) within 2 years of completing anti-thyroid tablet therapy (e.g. carbimazole); | ||
Currently taking beta-blockers; | Currently taking beta-blockers; | ||
| − | |||
====Acceptable==== | ====Acceptable==== | ||
Revision as of 16:09, 14 June 2012
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Donor / Recipient
Explanation of Condition
The thyroid gland produces thyroxine, which controls the body's rate of metabolism.
Guidance
Unacceptable
Malignant (cancerous);
Any thyroid disorder under investigation;
Graves disease (hyperthyroidism or thyrotoxicosis) within six months of treatment with radioactive iodine therapy;
Graves disease (hyperthyroidism or thyrotoxicosis) within 2 years of completing anti-thyroid tablet therapy (e.g. carbimazole);
Currently taking beta-blockers;
Acceptable
Hypothyroid (including Hashimoto thyroiditis) and stable on thyroid replacement therapy;
Benign thyroid tumour (e.g. oncocytoma);
If in doubt, discuss with medical officer.
Inform the transplant centre of all thryoid disease if requested for CT.
Pseudonyms or Related Conditions
Hypothyroidism
Hyperthyroidism
Hashimoto thyroiditis
Thyrotoxicosis
Graves disease/thyroiditis
Thyroid carcinoma
Oncocytoma of thyroid,
Version
Version 1, Edition 1
Date of Last Update
15th June 2012
